A pharmaceutical suspension is synthesized so that a considerable amount of salt is formed during neutralization. This microfine suspension must be cleansed (washed out) of salt and further concentrated. Initial salt concentration is about 10 % and the active ingredient is around 3.5 %. The desired final concentration is almost no salt (< 0.1 %) and 7.5 % active ingredient.

The fineness of the suspension requires microfiltration. With conventional crossflow technology a further concentration of the suspension is impossible due to the high viscosity. Therefore, dynamic crossflow filtration is required. Systems with rotating ceramic discs have too low throughput and require 100 m² filter area. Hence the BoCross Dynamic Filter is the only available technology for this challenging separation task.

Two 8 m² BoCross Dynamic Filters are applied for thickening and washing of this viscous suspension achieving the target values of 7.8 % active ingredient and 0.1 % salt.

BoCross Dynamic Filter L8 – Hygenic Design

Units installed

­

2

Filter area per unit

[m²]

8

Material

[ - ]

1.4435 (316 L)

Foot print

[m²]

2

Year of commissioning

[ - ]

2008

 

Process and Operation Data

Solids content in feed

[wt- %]

3

Solids content in retentate

[wt- %]

7.8

Solids content in filtrate

[g/l]

Free of particles

Washing out of salt

[–]

1 : 100

Operation pressure

[bar, g]

1.5–3.0

 

Product Data

Product   Iron hydroxide (pharmaceutical product)
Temperature [°C] 25–30

 

Noch Fragen? Ein Anruf genügt.

© 2020 BOKELA GmbH Karlsruhe, Germany
Beim Öffnen der Seite werden notwendige Cookies, Google Fonts, Google Maps, Youtube und Matomo geladen. Wenn Sie damit einverstanden sind, klicken Sie einfach auf Zustimmen. Weitere Details und Infos finden Sie in unserer Datenschutzerklärung und im Impressum.